Health Canada Approves CIMZIA® (certolizumab pegol) for Moderate-to-Severe Psoriasis - BioSpace

Health Canada Approves CIMZIA® (certolizumab pegol) for Moderate-to-Severe Psoriasis  BioSpace

Published: Mar 25, 2019. Health Canada also approves Label Updates in Pregnancy and Breastfeeding. OAKVILLE, ON, March 25, 2019 /CNW/ - UCB Canada ...